世界のペグ化タンパク質治療市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP07844)
◆英語タイトル:Global PEGylated Protein Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP07844
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ペグ化タンパク質治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ペグ化タンパク質治療の種類別市場規模(コロニー刺激因子、インターフェロン、エリスロポエチン(EPO)、組換え第VIII因子、モノクローナル抗体、酵素、その他)、用途別市場規模(がん、自己免疫疾患、肝炎、多発性硬化症、血友病、胃腸障害、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Merck、Horizon Pharma、Amgen、Pfizer、Roche、UCB、Biogen、AstraZeneca、Leadiant Biosciences
・地域別グローバル市場分析 2015年-2020年
・ペグ化タンパク質治療の北米市場(アメリカ、カナダ、メキシコ)
・ペグ化タンパク質治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ペグ化タンパク質治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ペグ化タンパク質治療の南米市場(ブラジル、アルゼンチン)
・ペグ化タンパク質治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:コロニー刺激因子、インターフェロン、エリスロポエチン(EPO)、組換え第VIII因子、モノクローナル抗体、酵素、その他
・用途別分析:がん、自己免疫疾患、肝炎、多発性硬化症、血友病、胃腸障害、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global PEGylated Protein Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 11600 million by 2025, from USD 10010 million in 2019.

The PEGylated Protein Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
PEGylated Protein Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, PEGylated Protein Therapeutics market has been segmented into:
Colony Stimulating Factor
Interferon
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibody
Enzyme
Others

By Application, PEGylated Protein Therapeutics has been segmented into:
Cancer
Autoimmune Disease
Hepatitis
Multiple Sclerosis
Hemophilia
Gastrointestinal Disorder
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global PEGylated Protein Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level PEGylated Protein Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global PEGylated Protein Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the PEGylated Protein Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and PEGylated Protein Therapeutics Market Share Analysis
PEGylated Protein Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, PEGylated Protein Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the PEGylated Protein Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in PEGylated Protein Therapeutics are:
Merck
Horizon Pharma
Amgen
Pfizer
Roche
UCB
Biogen
AstraZeneca
Leadiant Biosciences

【レポートの目次】

Table of Contents

1 PEGylated Protein Therapeutics Market Overview
1.1 Product Overview and Scope of PEGylated Protein Therapeutics
1.2 Classification of PEGylated Protein Therapeutics by Type
1.2.1 Global PEGylated Protein Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global PEGylated Protein Therapeutics Revenue Market Share by Type in 2019
1.2.3 Colony Stimulating Factor
1.2.4 Interferon
1.2.5 Erythropoietin (EPO)
1.2.6 Recombinant Factor VIII
1.2.7 Monoclonal Antibody
1.2.8 Enzyme
1.2.9 Others
1.3 Global PEGylated Protein Therapeutics Market by Application
1.3.1 Overview: Global PEGylated Protein Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Autoimmune Disease
1.3.4 Hepatitis
1.3.5 Multiple Sclerosis
1.3.6 Hemophilia
1.3.7 Gastrointestinal Disorder
1.3.8 Others
1.4 Global PEGylated Protein Therapeutics Market by Regions
1.4.1 Global PEGylated Protein Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of PEGylated Protein Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PEGylated Protein Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Horizon Pharma
2.2.1 Horizon Pharma Details
2.2.2 Horizon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Horizon Pharma SWOT Analysis
2.2.4 Horizon Pharma Product and Services
2.2.5 Horizon Pharma PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 UCB
2.6.1 UCB Details
2.6.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 UCB SWOT Analysis
2.6.4 UCB Product and Services
2.6.5 UCB PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biogen
2.7.1 Biogen Details
2.7.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biogen SWOT Analysis
2.7.4 Biogen Product and Services
2.7.5 Biogen PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Leadiant Biosciences
2.9.1 Leadiant Biosciences Details
2.9.2 Leadiant Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Leadiant Biosciences SWOT Analysis
2.9.4 Leadiant Biosciences Product and Services
2.9.5 Leadiant Biosciences PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global PEGylated Protein Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 PEGylated Protein Therapeutics Players Market Share
3.2.2 Top 10 PEGylated Protein Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global PEGylated Protein Therapeutics Revenue and Market Share by Regions
4.2 North America PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
5 North America PEGylated Protein Therapeutics Revenue by Countries
5.1 North America PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
5.2 USA PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe PEGylated Protein Therapeutics Revenue by Countries
6.1 Europe PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
6.2 Germany PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific PEGylated Protein Therapeutics Revenue by Countries
7.1 Asia-Pacific PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
7.2 China PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
8 South America PEGylated Protein Therapeutics Revenue by Countries
8.1 South America PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue PEGylated Protein Therapeutics by Countries
9.1 Middle East & Africa PEGylated Protein Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa PEGylated Protein Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global PEGylated Protein Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global PEGylated Protein Therapeutics Market Forecast by Type (2019-2024)
10.3 Colony Stimulating Factor Revenue Growth Rate (2015-2025)
10.4 Interferon Revenue Growth Rate (2015-2025)
10.5 Erythropoietin (EPO) Revenue Growth Rate (2015-2025)
10.6 Recombinant Factor VIII Revenue Growth Rate (2015-2025)
10.7 Monoclonal Antibody Revenue Growth Rate (2015-2025)
10.8 Enzyme Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global PEGylated Protein Therapeutics Market Segment by Application
11.1 Global PEGylated Protein Therapeutics Revenue Market Share by Application (2015-2020)
11.2 PEGylated Protein Therapeutics Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Autoimmune Disease Revenue Growth (2015-2020)
11.5 Hepatitis Revenue Growth (2015-2020)
11.6 Multiple Sclerosis Revenue Growth (2015-2020)
11.7 Hemophilia Revenue Growth (2015-2020)
11.8 Gastrointestinal Disorder Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global PEGylated Protein Therapeutics Market Size Forecast (2021-2025)
12.1 Global PEGylated Protein Therapeutics Market Size Forecast (2021-2025)
12.2 Global PEGylated Protein Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa PEGylated Protein Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Merck、Horizon Pharma、Amgen、Pfizer、Roche、UCB、Biogen、AstraZeneca、Leadiant Biosciences

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のペグ化タンパク質治療市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global PEGylated Protein Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。